JohnDanielSheppardJr.MDMMSc

Anterior Segment Related, Cornea & External Disease, Glaucoma Related, Uveitis

President, Virginia Eye Consultants Professor of Ophthalmology, Microbiology & Molecular Biology

Dr. Sheppard is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
241 Corporate Blvd
Norfolk, VA 23502
Phone+1 757-622-2200

Fax+1 757-622-4866

My practice includes referral cataract, corneal transplantation, ocular infection, ocular immunology, uveitis, complex surgical cases, 2nd opinions, ocular surface disease, dry eye, trauma and glaucoma in adult and pediatric patients. In addition I provide consultations, advisory boards, clinical trial participation, clinical trial design and expert opinions for pharmaceutical and surgical industry partners, academic and government institutions and medico-legal colleagues.

UC San FranciscoCornea, Uveitis, Immunology, Infection, International Blindness, 1986 - 1989
UPMC Medical EducationResidency, Ophthalmology, 1983 - 1986
United States NavyMMSc, Medicine, Brown University, 1979 - 1983
University of Virginia Medical CenterInternship, Pediatrics, 1978 - 1979
The Warren Alpert Medical School of Brown UniversityClass of 1978, MD, Sigma Xi Honorary

CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013
Fellow (FAAO) American Academy of Ophthalmology

PubMed

32 citations
Adenovirus Ocular Infections: Prevalence, Pathology, Pitfalls, and Practical Pointers.
Debora Garcia-Zalisnak, Christopher J. Rapuano, John D. Sheppard, Andrew R. Davis
Eye & Contact Lens. 2018-09-01
24 citations
Characterization of tear production in subjects with dry eye disease during intranasal tear neurostimulation: Results from two pivotal clinical trials.
John D. Sheppard, Gail Torkildsen, Joel A. Geffin, Jung Dao, David G. Evans
The Ocular Surface. 2019-01-01
47 citations
Effect of loteprednol etabonate 0.5% on initiation of dry eye treatment with topical cyclosporine 0.05%.
John D. Sheppard, Eric D. Donnenfeld, Edward J. Holland, Charles B. Slonim, Renée Solomon
Eye & Contact Lens. 2014-09-01

Clinical Challenges: Treatment Options for Dry Eye DiseaseMay 16th, 2023
Bausch + Lomb Presents Data from Second Pivotal Phase 3 Trial of Investigational Treatment NOV03 (Perfluorohexyloctane) at the Association for Research in Vision and Ophthalmology Annual MeetingMay 3rd, 2022
NOVALIQ PRESENTS DATA FROM SECOND PHASE 3 TRIAL OF INVESTIGATIONAL TREATMENT CYCLASOL® (0.1% CYCLOSPORINE OPHTHALMIC SOLUTION) AT THE AMERICAN SOCIETY OF CATARACT AND REFRACTIVE SURGERY ANNUAL M – PR NewswireApril 26th, 2022
Join now to see all

Associate & Mentor Examiner, American Board of Ophthalmology 1993 - Present
Association for Research in Vision & Ophthalmology, Media & Information Committee 1999 - 2003
American Academy of Ophthalmology, Basic Clinical Sciences Committee 1998 - 2001
American Academy of Ophthalmology, Media & Information Committee 1995 - 1999